These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6908278)
21. [Heart rate: a cardiovascular risk factor that can no longer be ignored]. Palatini P G Ital Cardiol (Rome); 2006 Feb; 7(2):119-28. PubMed ID: 16532723 [TBL] [Abstract][Full Text] [Related]
22. Preoperative stop or continue? New cardiovascular drugs. De Hert SG Acta Anaesthesiol Belg; 2001; 52(4):365-76. PubMed ID: 11799569 [No Abstract] [Full Text] [Related]
23. Medicine. Race and reification in science. Duster T Science; 2005 Feb; 307(5712):1050-1. PubMed ID: 15718453 [No Abstract] [Full Text] [Related]
24. Viewpoint: cardiac rehabilitation. Interview with Guy De Backer by Jennifer Taylor. De Backer G Circulation; 2006 Jun; 113(24):f95-6. PubMed ID: 16791933 [No Abstract] [Full Text] [Related]
25. [Aging and cardiology; various physiological, pathophysiological and clinical aspects]. Tukkie R; Düren DR; van den Brink RB; Lie KI Ned Tijdschr Geneeskd; 1997 Nov; 141(45):2163-6. PubMed ID: 9550797 [TBL] [Abstract][Full Text] [Related]
26. [Preventing the cardiotoxic effects of anthracyclines with Cardioxane]. Semiglazov VF Vopr Onkol; 1997; 43(6):569-74. PubMed ID: 9479353 [No Abstract] [Full Text] [Related]
27. Drugs and the elderly. Update: cardiac emergency drugs. Todd B Geriatr Nurs; 1986; 7(5):263-8. PubMed ID: 3638252 [No Abstract] [Full Text] [Related]
28. Advances in cardiovascular medicine. Siva A; Shah A Practitioner; 2005 Jun; 249(1671):461-5. PubMed ID: 15966280 [No Abstract] [Full Text] [Related]
29. [Protective systems of the human organism as a basis of search and development of new original medical drugs]. Chazov EI Vestn Ross Akad Med Nauk; 2012; (5):6-7. PubMed ID: 22856158 [No Abstract] [Full Text] [Related]
30. Pharmacological update: New drugs in cardiac practice: A critical appraisal. Magoon R; Choudhury A; Malik V; Sharma R; Kapoor PM Ann Card Anaesth; 2017 Jan; 20(Supplement):S49-S56. PubMed ID: 28074823 [TBL] [Abstract][Full Text] [Related]
31. [COPD with concomitant cardiac disease. Which cardiac medicine can he tolerate?]. Stiefelhagen P MMW Fortschr Med; 2005 Jun; 147(24):12. PubMed ID: 16001524 [No Abstract] [Full Text] [Related]
34. Cardiotoxicity and cardioprotection in breast cancer chemotherapy. The role of dexrazoxane. Venturini M Clin Ter; 1998; 149(921):5-6. PubMed ID: 9621480 [No Abstract] [Full Text] [Related]
35. Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging. Noutsias M; Kuehl U; Lassner D; Gross U; Pauschinger M; Schultheiss HP; Gutberlet M Circulation; 2007 Apr; 115(13):e378-80. PubMed ID: 17404165 [No Abstract] [Full Text] [Related]
37. Trimetazidine revisited: a comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine. Onay-Besikci A; Ozkan SA Cardiovasc Ther; 2008; 26(2):147-65. PubMed ID: 18485136 [TBL] [Abstract][Full Text] [Related]
39. [Prognosis of heart failure--value of drug therapy]. Felix SB Z Kardiol; 1996; 85 Suppl 4():1-7. PubMed ID: 9027102 [TBL] [Abstract][Full Text] [Related]